Current biomaterials for auricular replacement are associated with high rates of infection and extrusion. The development of new auricular biomaterials that mimic the mechanical properties of native tissue and promote desirable cellular interactions may prevent implant failure. A porous 3D nanocomposite scaffold (NS) based on POSS-PCU (a polycarbonate soft segment and a polyhedral oligomeric silsesquioxanes nanocage) was developed with an elastic modulus similar to native ear. In vitro biological interactions on this NS revealed greater protein adsorption, increased fibroblast adhesion, proliferation and collagen production compared with Medpor® (the current synthetic auricular implant). In vivo the POSS-PCU with larger pores (NS2; 150-250μm) had greater tissue ingrowth (~5.8× and ~1.4× fold increase) than the POSS-PCU with smaller pores (NS1; 100-50μm) and when compared to Medpor® (>100μm). The NS2 with the larger pores demonstrates a reduced fibrotic encapsulation compared with NS1 and Medpor® (~4.1× and ~1.6× fold respectively; P<0.05). Porosity also influenced the amount of neovascularisation within the implants, with no blood vessel observed in NS1 (12wks post-implantation). The lack of chronic inflammatory response for all materials may indicate that the elastic modulus and pore size of the implant scaffold could be important design considerations for influencing fibrotic responses to auricular and other soft tissue implants.
Introduction
Approximately 2 in 10,000 children are born with an ear deformity (e.g. including microtia and anotia), whilst traumatic injuries and malignant lesions (13% of all head and neck melanomas) add to the need for ear replacement and reconstruction. [1] [2] [3] Off-the-shelf synthetic auricular implants offer a number of advantages to routine autologous costal cartilage reconstruction surgery currently performed including; a reduced cost and length of operation, and no donor site morbidity. [4] Despite synthetic scaffolds being used for over 50 years in the auricular reconstruction surgery, they suffer from high failure rates. Medpor® auricular implants are the most commonly used auricular synthetic framework. Failure rates of between 11%-40% (depending on whether a temporoparietal fascia flap (TPFF) approach was used) have, however, been reported with the use of Medpor®. [5] [6] [7] There is, therefore, a real clinical need to develop improved biomaterials that are designed to have desirable biological interactions and reduced the failure rates.
The host tissue integration and vascularisation following implantation of auricular constructs depends upon both material surface properties (e.g. chemistry, topography, micro-mechanical properties) and bulk properties (e.g. pore size, porosity, and mechanical properties). [8] [9] [10] [11] [12] The material surface properties determine, the type, quantity and surface confirmation of protein interactions, which governs subsequent cellular interactions, which in turn may affect fibrotic encapsulation. [13] Fibrotic encapsulation has been previously reported as a cause of implant extrusion and failure. [14] [15] [16] Optimising these cell-material interactions may, therefore, reduce fibrotic encapsulation and failure rates of auricular implants.
Macrophages play an important part of the wound healing response when materials are implanted into tissues and express a large array of cytokines and chemoattractants, which modulate the behaviour of numerous cell types. [17] [18] [19] Macrophage behaviour can change depending on the adsorbed protein and the material surface properties. [20] [21] [22] Ensuring that the biomaterial invokes a healing inflammation response, has the mechanical properties to resist unintentional wear and degradation and reduce implant fibrotic encapsulation is necessary for the long-term survival of the implants.
Neovascularisation is also vital for tissue regeneration and repair by supplying gases and nutrients for cells and tissues, and is a crucial parameter for supporting new tissue ingrowth in porous implants. Vascular endothelial growth factor (VEGF) is a key mediator for angiogenesis and granulation tissue formation in the early stage of healing, [23, 24] and can be expressed by fibroblasts within the peri-implant tissue. VEGF binds to its respective receptors, which are expressed on endothelial cells (ECs) and play important roles in transducing signals to induce angiogenesis in vivo through proliferation, migration and differentiation of ECs as well as regulates microvascular permeability. [25] Several studies have highlighted that an inadequate vascular supply and fibrous tissue ingrowth can be a cause of auricular implant failure due to the consequential flap ischemia or necrosis. [26] [27] [28] Indeed using vascularised grafts to completely covers the auricular Medpor® implants has significantly improved the short-term complication rates. [9] Previous studies have developed a porous nanocomposite scaffold (NS), named polyhedral oligomeric silsesquioxane nanocage into polycarbonate based urea-urethane (POSS-PCU), for personalised auricular reconstruction using glass moulds and 3D-printing technology to replicate the shape of the original human auricle (Figure 1 ). [29] We have also demonstrated that these NSs had an elastic modulus similar to native ear cartilage (5.7 MPa vs. 5.0 MPa), compared with Medpor® (141 MPa) (Supplementary Table S1 ). Matching the elastic modulus of the native ear may be important in preventing elastic modulus mismatch between the scaffold and the surrounding tissue. A material considerably stiffer than the surrounding tissue may cause micro-movement (when multilateral force is applied) and subsequently promote further fibrotic encapsulation, migration of the implant, and extrusion. Our simple approach is to create an "off-the-shelf" technology, whereby the scaffold matches and replaces the mechanical role of the ear cartilage and to improve the biological interactions of the scaffold with the surrounding dermal tissue. POSS-PCU has been also used successfully in first-in-man applications for replacement of coronary arteries, lacrimal ducts, and the world's first synthetic trachea. [30] [31] [32] Here, we investigate the biological interactions of these NSs (compared to Medpor®) in vitro and in vivo, to assess the potential of the POSS-PCU NS as a substitute biomaterial implant for auricular cartilage replacement. The NS interaction with serum proteins, human dermal fibroblasts (HDFs) and macrophages were studied. The cellular behaviour, inflammatory and angiogenic response of the cells on these NSs were also investigated. To this end, the NS with two different pore sizes were subcutaneously evaluated in vivo in a rodent model for upto 3 months, and compared with Medpor®.
Results and Discussion

In vitro evaluation of NS materials
Biomaterials designed for auricular reconstruction need to be able to support and maintain the auricular shape and be able to integrate with the sub-dermal layer. The materials properties (including surface chemistry, topography, mechanical properties, porosity and pore size) may be important in determining both 1) the initial material-cell interactions including initial protein adsorption, subsequent cell attachment and 2) inflammatory response, tissue ingrowth into the scaffold, ECM production and fibrous encapsulation. [33] [34] [35] [36] [37] [38] Here we investigated if both these initial biological interactions and subsequent implant fibrotic encapsulation can be manipulated by the material physicochemical properties.
To compare protein adsorption on NS and Medpor®, we immersed them in foetal bovine serum protein media for 24 hrs. An increase in the total concentration of protein adsorption was observed between both samples, with NS showed the greatest total percentage of protein adsorption (76.16% ± 7.5 μg/ml), compared to Medpor® (43.00% ± 2.6 μg/ml) within 24 hrs (Figure 2a) . Protein absorption is both protein and substrate dependent and can be affected by the surface area (surface topographical features and porosity), as well as surface chemistry. [13, 39] Table S1 ). [29] The increased surface area of the NS caused by the increase in porosity and nanoscale topography will provide a larger surface area for the serum proteins to be adsorbed than Medpor®. NS is also less hydrophobic (53.24±0.13º) than Medpor® (45.67±0.23º) (Supplementary Table S1 ). The physiological effect of hydrophobicity on protein adsorption has been previously discussed, increased affinity between proteins and material surface may increase protein attachment but may also distort the original conformational of 3D protein structure, and thereby distort the cell receptor binding motifs and render them inactive. [40] Increased adhesion of HDFs (human dermal fibroblasts) on NS was observed in the dynamic and static conditions, after 24 hrs culture, compared to Medpor® (Figure 2ba,bb) . The adhesion strength of cells in the native and continuous dynamic motion in vivo and the effects on wound healing and stability have been previously reported. [41] The increased cell adhesion on NS in both dynamic and static conditions could be explained by the increase in the adsorbed proteins and the increased surface area. The nanotopography of the NS may also have a direct effect on the adhesion strength of cells. Fibroblast filopodia number has been previously shown to increase on nano-featured surfaces compared to micro-featured surfaces. [42, 43] In addition to increased cell attachment, NS also showed an increased number of cells and total metabolic activity over a 14 day culture period (Figure 2ca ,cb) compared to Medpor®, although there was no difference in the rate of proliferation, and cell metabolic activity/μg DNA (Figure 2cc, Supplementary Figure 2) . This suggests that number of cells on the scaffolds was proportional to the initial cell attachment. The increase in metabolic activity shown in this study is contrary to our previously study where we reported no difference in metabolic activity of carcinogenic (3T3) cell-line between Medpor® and NS surfaces, [29] this may be because the primary HDFs are more sensitive to environmental changes than the cancerous cells used previously.
The increased production of collagen hydroxyproline by HDF on NS compared to Medpor® (~2× fold, Figure 2da ) may be due, in part, to the increased cell number (Figure 2ca) . A higher collagen production/μg DNA (Supplementary Figure 2) was, however, observed and this could be due to the differences in the physicochemical properties of the scaffold (topography, surface chemistry etc), increased concentration of collagenic growth factors (e.g. TGFβ) in the media due to increased cell number, and/or increased juxtacrine signalling. [44, 45] The production of collagen is important for wound healing following invasive implantation, implant integration and tissue ingrowth, as well as to provide cellsignalling motifs (ligands) and growth factors for guiding cell behaviour. [19, 46] Prolonged expression or overproduction of specific type of collagen (Coll-1α) may, however, contribute to increased fibrotic encapsulation. [47, 48] Interestingly the increase of collagen hydroxyproline on NS was consistent with the reduced production of TNF-α cytokine, compared with Medpor® (Figure 3da ), which shown that the lowest level of this cytokine inhibit collagenase production. [49, 50] There was no difference in total VEGF production of NS (269.2 ± 17.56 pg/ml) over time of VEGF production/μg DNA was, however, observed on Medpor® compared with NS
(Supplementary Figure2
). This increase could possibly be caused by the previously reported increase in VEGF production on stiffer surfaces. [51, 52] Initial cytokine release profiles were also measured in an effort to evaluate if the different surfaces of NS and Medpor® scaffolds changed the behaviour of macrophages through the release of IL-1β, TNF-α, and IL-10 cytokines, which are important mediators of the inflammatory response and wound healing. [20] The total amount of both IL-1β and IL-10 inhibition of NFĸB activation. [53] Both IL-1β and TNF-α cytokines are essential for wound healing because they induce neutrophil recruitment, maturation and encourage angiogenesis.
Prolonged expression or overproduction of these cytokines in the inflammatory phase may, however, cause granulation tissue formation and subsequently increased fibrotic encapsulation. [50, 54, 55] Interestingly the reduced pro-inflammatory TNF-α observed by macrophages on NS surfaces in vitro was consistent with a reduced thickness of the fibrotic capsule in vivo, compared to Medpor® (Figure 3da, Figure 4cd ).
Macrophage behaviour and subsequent inflammatory response can be affected by the surface chemistry and surface topography of the material. [53, [56] [57] [58] The inflammatory response (lower expression of TNF-α and IL-1β pro-inflammatory cytokines/μg DNA on NS surfaces compared to Medpor®, Supplementary Figure 3ca ,cb), may be due to differences in surface chemistry and topography between these materials (Supplementary Table S1 ). The scale and spatial arrangement of the nano-topographical features on the nanocomposite scaffold may be partly responsible for this reduced pro-inflammatory response. Previous studies have
shown that nanostructure features on titanium surfaces reduced the secretion of proinflammatory cytokines from macrophages. [22] The increased expression of pro-inflammatory cytokines IL-1β/μg DNA and TNF-α/μg DNA (Figure 3cb ,db,eb), and reduced anti-inflammatory cytokine IL-10/μg DNA following endotoxin (LPS) challenge indicates that the macrophages can respond to inflammatory stimuli through NFĸB activation pathway, and, hence, confirming that the scaffold autoclaving/cleaning technique is successful in removal of the majority of endotoxins.
[59]
In vivo evaluation of NS implants
In vivo studies of the NSs made of two different pore sizes ranging from 50-100µm (NS1) and 150-250µm (NS2), but with a constant weight ratio of porogen particles to polymer was assessed by subcutaneous in situ implantation in the back of a rodent model, and compared with Medpor® (>100 µm). Here, the pore size of NSs was varied slightly to examine the effect of the changes on tissue ingrowth, angiogenesis and fibrotic response (which are not possible to measure in vitro). These pore sizes were chosen as an interconnective pore size of greater than 100 µm is required to accommodate a hierarchical vascular network within a scaffold, [60] with compromising the mechanical properties to native ear cartilage (Supplementary Table S1 ).
On removal of the implants the scaffolds with the larger pore sizes (NS2 and Medpor®) were firmly anchored within the subcutaneous tissue compared to the NS1 (after a 12 wk implantation period, Figure 4aa ,ac). The NS2 was, however, considerably harder to remove . This thickening may be explained through the effect of increased substrate stiffness on myofibroblast formation, proliferation and collagen overproduction. [55, [61] [62] [63] The nanocomposite scaffolds have a more similar elastic modulus to the surrounding native ear tissue (compared to Medpor® implant) and may therefore reduce these phenomena Table 1) . [29] Softer substrates have been reported to reduce myofibroblast proliferation and the production of factors associated with fibrotic capsule formation (e.g.
collagen type 1, α-smooth muscle actin (α-SMA)). [55] The poor cellular infiltration within the scaffolds with smaller pores (NS1) may also be contributing factor that prevents tissue embedded scaffold anchoring, thereby increasing interfacial micro-movement, and possibly contributing to inflammation and fibrotic capsule formation. A thicker capsule formation has been previously reported on non-porous silicone scaffolds compared to the porous Medpor® for auricle replacement. [64] Pores beneath a certain size, may cause a similar response to no pores, whereby the fibrotic membrane does not "dip" into the scaffold pores but is continuous. This would allow a greater fibre alignment and thereby "force" emitted on the material (Figure 4Cb ). The thickness and type of fibrous encapsulation may be important in the force submitted on the material, implant migration and possibly extrusion. Medpor® implants have been reported to have extrusion rates of 58% and 28%, within the rabbit and ovine auricular cartilage models, respectively. [65, 66] The larger pore sizes of NS2 and Medpor® implants supported the formation of new internal NSs could be the potential for a greater ability to integrate in the host environment. This is important because fibrovascular encasing of the implanted material is necessary for its anchorage in situ and for minimizing the occurrence of graft extrusion, as previously reported. [68] [69] [70] [71] The NS2 and Medpor® materials exhibited a similar inflammatory profile (both within the scaffold and within the fibrotic membrane), as determined by the average number of CD68+ Normal healing reactions without the chronic inflammatory response of these material implants was similar to that described in other animal models and in human using Medpor® implant. [65, 66, 72, 73] As opposed to the more complicated and costly tissue engineering approaches, in this study,
we have shown that biomaterials designed with appropriate mechanical stiffness, surface properties and porosity, can influence biological interactions including fibrotic encapsulation.
The lack of a chronic inflammatory response (as shown here and previously reported for Medpor®), may indicate that either the model is not suitable for examining soft-tissue implant failure (e.g. duration of experiments, site of tissue or modelling micro-movement) or that the high failure/extrusion rates shown could be via a different non-inflammatory mechanism. Here we postulate that the type and size of fibrotic membrane formation surrounding the implants is important in determining extrusion rates and that the physicochemical properties of the implant scaffold (in particular the substrate stiffness) can be tailored to minimize this response.
Conclusion
Here we demonstrated that controlling the physicochemical properties of a biomaterial influences soft-tissue implant interactions (including fibrotic encapsulation) and can therefore lead to the design-led development of auricular implants that reduce failure rates. The in vitro and in vivo preclinical models used in this study provided, respectively, a setting to evaluate the clinical suitability and the subcutaneous behaviour of NSs, which had an elastic modulus closer to native ear cartilage (compared with the currently used auricular Medpor® implant).
We demonstrated that NSs showed greater protein adsorption, and subsequently increased HDF adhesion (at both static and dynamic conditions), proliferation, and collagen production 
Experimental Section
Synthesis of Nanocomposite Polymer: POSS-PCU nanocomposite polymer was synthesised as described previously. [74] Briefly Fabrication of Nanocomposite Scaffolds: NSs were synthesized and produced through optimized solvent evaporation and porogen leaching fabrication methods, as previously described. [29] The weight ratio of NaCl particles to POSS-PCU was controlled to 3:7 as with the previous studies. NSs with an average pore size of 150 μm, and a thickness of 700-800 μm, were cut into 16 mm diameter discs for use in 24 well plates, and used for in vitro cell culture experiments (n=4). Tissue culture plastic (TCP) used as control sample. The same NS discs (16mm in diameter), but with different thickness (~1.5 mm) and different pore sizes ranging from (50-100 μm) and (150-250 μm) were used for in vivo implantation (n=4 NS each time point). The pore size and morphology of these NSs was confirmed using scanning electron microscopy (SEM) (Supplementary Figure 4) . Micro thin Medpor® medical grade high-density porous polyethylene (HDPE) (Porex Surgical, Newnan, GA USA) (1.5 mm thickness sheets) with a manufacturer-specified pore size of larger than 100 μm and a pore volume of 50% were cut into circle-shaped disks (16 mm in diameter), and used for were implanted subcutaneously at 1 cm from the site of incision. After 4, 8, and 12 wks, the implanted materials plus surrounding tissue were dissected from the subcutaneous pocket.
Extracted samples (peri-implant tissue included) were labelled (orientation noted) and fixed in 10% (v/v) NBF before paraffin embedded for standard histology analysis to assess tissue ingrowth and fibrous capsule thickness, and IHC to assess micro-neovascularisation and the host inflammatory responses using von Wilibrand Factor (vWFs) and CD68 staining, respectively (see Supplementary Information and the Methodology section). Thereafter, the animals were sacrificed by cervical dislocation.
Statistic: All quantitative data are presented as means ± standard deviation (SD). The differences between samples during repeated-measures testing was calculated by one-way or two-way analysis of variance (ANOVA) using Tukey's post hoc test, or two-tailed unpaired Student t-tests (for parametric data), with significance accepted at the 5% level using
GraphPad Prism 6 Software.
Supporting Information
Supporting Information is available from the Wiley Online Library or from the author. ca, higher HDFs number and cb, higher metabolic activity were presented on NS compared with Medpor® at day 7 and 14. cc, No significant differences in cell proliferation rate were observed between the scaffolds after 14 days of culture (% of total DNA relate to day 1). da, A significantly higher amount of collagen production was found on NS over 14 days culture. db, no significant difference in level of VEGF production was observed between both scaffolds over 14 days. *P < 0.05, errors bar=SD, (n=4, scaffolds in each group at each time-point). 
Supplementary Information Supplementary Experimental Section
Physicochemical characterisation of materials. The surface chemistry, topography, and mechanical properties of the POSS-PCU nanocomposite scaffold (NS) and Medpor® have been previously characterised and the protocols were published in detail. [1] The changes in the pore size of NSs changed the mechanical and total porosity, but not the chemistry. A table summary of the physicochemical properties of these materials was presented (Supplementary Table 1 ).
In vitro biological interactions
Fibroblast culture. Human dermal fibroblast (HDF) cell derived from the dermis of normal human neonatal foreskin or adult skin (ECACC, UK, Number 06090715), were cultured in Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% foetal bovine serum (FBS) and 1% antibiotic (50 μg/mL streptomycin, 50 U/mL penicillin) solutions (all from Invitrogen, UK) and incubated at 37 •C. The 16 mm polymer discs (n=4) were autoclaved, washed in sterile phosphate-buffered saline (PBS) and pre-incubated in 1 ml of supplemented Connective tissues enmeshed with spindle-shaped fibroblasts were considered as an ingrown fibrous tissue; while round-shaped cells and rare spindle-shaped fibroblasts in the most inner area were considered as non-ingrown fibrovascular tissues as previously described. Table 2 ). * 3% hydrogen peroxide diluted in Methanol-30 min (Sigma Aldrich) used to inhibit endogenous peroxidase activity. Hoechst 33258 was used as the nuclear stain. As negative controls, immunohistological stained in the absence of the primary antibody.
Blood vessels formation was identified via immunolocalization with the ECs marker, vWF.
The percentage volume fraction of the stained microvasculature within each host tissue of implanted scaffolds (total percentage microvessel area (mm 2 )) was estimated by using the previously described technique of area counting overlying small blood vessels for each evenly random selected field of view. All estimations were analyzed at a final magnification of 40× and 32 fields of view for each scaffold (n=4). The volume fraction was considered the main tissue within scaffold related parameter characterizing the extent of neovascularization (reflecting both the number and size of new small blood vessels). higher collagen production per cell was observed on NS than Medpor® over 3 days , followed by non-significant increase after day 7. b, A significantly higher VEGF release per cell was obtained on
Medpor® than NS at 14 days. aa, No significant difference in total U937 cell number and ab, in rate of cell proliferation (% of total DNA relate to day 1) was observed on both NS and Medpor® scaffolds over 72 hrs. ba, and bb, Scanning electron microscopy (SEM) micrograph images of transformed adhered U937 macrophages with rounded cell morphology (red arrow) after 3 days culture on NS and Medpor®. ca, and cc, No significant differences in IL-1β/μg DNA, and IL-10/μg DNA cytokines production was observed on both NS and Medpor® after 72 hrs, apart from cc, TNF-α/μg DNA that presented a significantly lower production on NS than Medpor®. 
